Description:

Gynecologic Oncology Group Surgical Reporting Form (Form C) NCT00951496 Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=4F53ABD3-7FB6-64F0-E044-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=4F53ABD3-7FB6-64F0-E044-0003BA3F9857

Keywords:
Versions (3) ▾
  1. 9/19/12
  2. 1/9/15
  3. 7/3/15
Uploaded on:

July 3, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Gynecologic Oncology Group Surgical Reporting Form (Form C) NCT00951496

No Instruction available.

  1. StudyEvent: Gynecologic Oncology Group Surgical Reporting Form (Form C)
    1. No Instruction available.
Header Module
Header
Operative procedure performed (check all that apply)
Surgical approach
Stage
%
Residual gross tumor
cm
Microscopic disease only
Ascites
Cytology of peritoneal or ascitic fluids
Summary of operative findings (*)
Exam (*Examined: 1=tumor present; 2=no tumor; 3=suspicious; 4=organ absent; 5=not examined)
Proc (*Procedure: 1=removed partially; 2=removed completely; 3=biopsy only; 4=left intact; 5=not applicable)
Comments

Similar models